CareDx (CDNA) Tops Q1 EPS by 14c; Raises Revenue Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. META
6. TSLA
7. RTX
8. SMCI
9. GOOGL
10. S

Go back to CareDx (CDNA) Tops Q1 EPS by 14c; Raises Revenue Guidance

CareDx Reports First Quarter 2021 Results

May 5, 2021 4:01 PM EDT

SOUTH SAN FRANCISCO, Calif., May 05, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today reported financial results for the first quarter ended March 31, 2021.

Recent Highlights:

Achieved total revenue of $67.4 million for the three months ended March 31, 2021, increasing 76% year-over-yearTotal AlloSure and AlloMap patient results provided in the quarter were approximately 33,200, which includes approximately 5,900 AlloSure Heart patient... More